Cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries

Posted on by

Vaccine
http://www.sciencedirect.com/science/journal/0264410X
Volume 28, Issue 47 pp. 7453-7576 (3 November 2010)

Letters to the Editor
An update to “The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe”
Pages 7457-7459
Mark Jit, Marie-Josée J. Mangen, Hugues Melliez, Yazdan Yazdanpanah, Joke Bilcke, Heini Salo, W. John Edmunds, Philippe Beutels

Abstract
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.